dc.date.accessioned | 2021-06-08T15:46:15Z | |
dc.date.available | 2021-06-08T15:46:15Z | |
dc.date.created | 2021-06-08T15:46:15Z | |
dc.date.issued | 2021 | |
dc.identifier | https://hdl.handle.net/20.500.12866/9517 | |
dc.identifier | https://doi.org/10.7883/yoken.JJID.2020.729 | |
dc.description.abstract | Fabry disease (FD), like COVID-19, can affect multiple organs, including the lungs. Patients with FD are expected to develop severe COVID-19, due to involvement of not only the lungs but also the kidneys and the presence of other comorbidities. We present 2 cases of mild COVID-19 in patients with FD who were infected with the COVID-19 virus. Although it is unknown whether the X chromosome mutation in patients with FD affects the development of severe COVID-19, it is suggested that it may play a protective role against COVID-19 infection. Based on these cases, we suggest that FD is not a risk factor for severe COVID-19 | |
dc.language | eng | |
dc.publisher | J-STAGE | |
dc.relation | Japanese Journal of Infectious Diseases | |
dc.relation | 1884-2836 | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | COVID-19 | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Middle Aged | |
dc.subject | COVID-19 Testing | |
dc.subject | COVID-19/diagnostic imaging/*etiology/therapy | |
dc.subject | Enzyme Replacement Therapy | |
dc.subject | fabry disease | |
dc.subject | Fabry Disease/*etiology/genetics/therapy | |
dc.subject | Kidney/pathology | |
dc.subject | rare diseases | |
dc.title | When Frequent (Pandemic) Occurs in a Non-Frequent Disease: COVID-19 and Fabry Disease: Report of Two Cases | |
dc.type | info:eu-repo/semantics/article | |